Ticker
IRWDCompany Name
IRONWOOD PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
---|---|---|---|
6/30/2025 | $ 641.61M | 21.43 | $ 29.94M |
3/31/2025 | $ 609.38M | 7.77 | $ 78.41M |
12/31/2024 | $ 748.78M | 7.24 | $ 103.41M |
9/30/2024 | $ 1.27B | 10.28 | $ 123.82M |
6/30/2024 | $ 1.18B | 8.07 | $ 146.36M |
3/31/2024 | $ 1.64B | 11.09 | $ 147.91M |
12/31/2023 | $ 2.91B | 15.86 | $ 183.15M |
9/30/2023 | $ 2.12B | 9.33 | $ 226.74M |
6/30/2023 | $ 2.14B | 8.12 | $ 263.36M |
3/31/2023 | $ 1.32B | 4.55 | $ 289.67M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV / FCF
(=) EV/FCF
EV/FCF for IRONWOOD PHARMACEUTICALS INC is calculated as follows: EV [ $ 1.75B ] / FCF [ $ 140.43M ]
(=) EV/FCF [ 12.46 ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 2.2K |
---|---|
min | 0.05 |
max | 77.98 |
average | 23.46 |
median | 19.08 |
std | 16.15 |